|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo显示文摘 | Wenwen Chien Dhong Hyun Lee Yun Zheng Peer Wuensche Rosie Alvarez Ding Ling Wen Ahmed M. Aribi Su Ming Thean Ngan B. Doan Jonathan W. Said H. Phillip Koeffler | 2014 | Mol. Carcinog2014，，9： | 1 |
| 2 | Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumabozogamicin in recurrent acute promyelocytic leukemia显示文摘 | Aribi A Kantarjian HM Estey EH | 2007 | Cancer2007，109，7： | 1 |
| 3 | Activity of decitabine in the treatment of patients with chronic myelomonocytic leukemia显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 4 | Two cases of discitis due to propionibacterium acnes显示文摘 | Claudepierre P Aribi EH | 1998 | Rev Rhum Engl Ed1998，65，1： | 1 |
| 5 | Boric acid toxicity to the German cockroach, BlatteUa germanica: Alterations in midgut structure, and acetylcholinesterase and glutathione S- transferase activity显示文摘 | Habes D Morakchi S Aribi N | 2006 | Pestic Biochem Phys2006，84，： | 1 |
| 6 | T-cell large granular lympho- cytic (T-LGL) leukemia: experience in a single institution over 8 years显示文摘 | Aribi A Huh Y Keating M | 2007 | Leuk Res2007，31，7： | 1 |
| 7 | Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia 显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 8 | Combination therapy with arsenic trioxide,all-trans retinoic acid,and gemtuzum ab ozogamicin in recurrent acute promyelocytic leukemia显示文摘 | ARIBI A KANTARJIAN HM ESTEY EH | 2007 | Cancer2007，109，7： | 1 |
| 9 | Bipheno- typic acute leukaemia:a case Series显示文摘 | Ahmed Aribi Carlos Bueso-Ramos Eli Estey | 2007 | British Journal of Haem- atology2007，138，： | 1 |
| 10 | Activity of decitabine,a hypomethylating agent,in chronic myelomonocytic leukemia显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 11 | Ac-tivity of decitabine,a hypomethylating agent,in chro-nic myelomonocytic leukemia显示文摘 | ARIBI A BORTHAKUR G RAVANDI F | 2007 | Cancer2007，109，： | 1 |
| 12 | Activity of decitabine, a hypomethylating agent, in chronic myelomonocyticleukemia 显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 13 | Activity of decitabi- he, a hypomethylating agent in chronic myelomonocyticleu- kemia 显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 14 | arsenic trioxide, all-trans retinoic acid,and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia显示文摘 | ARIBI A KANTARJIAN Combination therapy with H M ESTEY E H | 2007 | Cancer2007，109，： | 1 |
| 15 | The effect of interleukin 11 on thrombocytopeniaassociated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia显示文摘 | Aribi A Kantarjian H Koller C | 2008 | Cancer2008，113，6： | 1 |
| 16 | Clinical evaluation of lipids, lipoproteins and red blood eells sodium and potassium in patients with different grades of hypertension显示文摘 | Aribi M Merzouk H~ Haddouche M | 2010 | Clinieal Biochemistry2010，43，12： | 1 |
| 17 | Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia 显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 18 | Biphenotypic acute leukaemia:a case series显示文摘 | Aribi A Bueso-Ramos C Estey E | 2007 | Br J Haematol2007，138，2： | 1 |
| 19 | Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly pa- tients:a prospective randomized trial in Algeria 显示文摘 | Aribi M Mesli N Remla N | 2010 | J Cancer Res Ther2010，6，1： | 1 |
| 20 | Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: a prospective randomized trial in Algeria 显示文摘 | Aribi M Mesli N Remla N | 2010 | J Cancer Res Ther2010，6，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员